You are here

Eli Lilly

Lilly has a rich pipeline with a number of marketed medicines including oncology and diabetes. Quantitative pharmacology (model-based decision making) has been widely used and applied throughout different stages of drug development at Lilly.

Lilly staff will provide expertise in relevant therapeutic areas, drug development process and methodology issues needed by the project. The three PIs involved in the project are experts in the field of modelling and simulation in pharmacology and have practical experience in clinical trial designs and PK/PD analysis. In particular they are recognised authorities in oncology and optimal design.



Associated members

Azhar Khan's picture
Azhar Khan
Eli Lilly
Celine Pitou's picture
Celine Pitou
Eli Lilly
Eunice Yuen's picture
Eunice Yuen
Eli Lilly
Ivelina Gueorguieva's picture
Ivelina Gueorguieva
Eli Lilly
Sonya Tate's picture
Sonya Tate
Eli Lilly